ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

NSABP Donates Sculpture to NIH to Commemorate 50th Year.

September 19, 2008

NCAB ‘Incredulous’ Over Proposed Ethics Rules, Bard Members Threaten Resignation In Letter

October 4, 1991

NIAID Advisors Ok Women & Infants Study Continuation

February 21, 1992

CMX001 Reduces Adenovirus Progression and Viremia

August 30, 2013

ASCO Recommends Discussing Pharmacological Prevention

July 26, 2013

Cancer Telethon Attracts Small Audience, Generates Expectations-And Questions.

September 12, 2008